This cross-sectional study assessed changes in opioid prescribing patterns for oculoplastic and orbital procedures after enactment of the Michigan Opioid Laws in 2017 and 2018.

This study assessed whether the rate of geographic atrophy enlargement is influenced by subsequent exudative neovascular AMD.

Investigators longitudinally examined long-term alterations in the foveal avascular zone in patients with preclinical Alzheimer disease.

This week, researchers grow tear-gland organoids in a dish, new retinal scan technology detects early childhood autism and a study reveals the toll of dry eye on patients’ overall well-being.

This study characterized the rates of PRP and anti-VEGF medications before and after publication of the Diabetic Retinopathy Clinical Research Network Protocol S.

The University of Edinburgh is awarding 12 scholarships in their Master of Surgery in Clinical Ophthalmology program.

This week, a treatment for retinitis pigmentosa receives orphan drug status, the OMNI platform becomes the first MIGS device cleared for open-angle glaucoma and researchers integrate biosensors into soft contact lenses.

This prospective randomized trial evaluated the efficacy of phacoemulsification combined with either endocycloplasty (ECPL) or trabeculectomy for primary angle-closure glaucoma.

This study describes the posterior segment manifestations of Ebola survivors in Sierra Leone.

This prospective study compared the performance of retinal specialists and artificial intelligence (AI) algorithm in detecting retinal fluid from spectral-domain OCT scans.

Researchers characterized orbital roof fractures in adults who presented at a single level 1 tertiary care center between 2015 and 2018.

This week, scientists discover new glaucoma-related genetic variants, the pandemic adds to the prevalence of myopia and Tennessee locals spot a deer with a rare case of corneal dermoids.

These studies examined cases of vision loss after a diagnosis of COVID-19.

In this population-based analysis, investigators evaluated ophthalmologic disorders associated with autism spectrum disorder.

This week, MRI evaluations reveal globe abnormalities in patients with COVID-19, a new antibody-based drop for dry eye wins $10 million in grant support and a gene therapy for geographic atrophy shines in clinical trials.

The authors of this study evaluated transmission of SARS-CoV-2 from individuals with no symptoms.

This cross-sectional study assessed ophthalmic features specific to Ebola virus disease.

Investigators compared outcomes between unilateral and bilateral trifocal diffractive IOL implantation in emmetropic patients with presbyopia.

Researchers used the 8th edition of the American Joint Committee on Cancer (AJCC) Cancer Staging Manual to evaluate metastatic and mortality rates among children with retinoblastoma.

Investigators evaluated the visual and corneal outcomes of new generation hybrid contact lenses in patients with advanced keratoconus.

This week, gene therapies for achromatopsia and Stargardt gain the FDA’s attention, a betamethasone-based treatment for postoperative pain and inflammation shows promise and a new study reveals the danger of hand sanitizers among children.

This week, a travoprost intracameral implant shows encouraging phase 1 results, the ILM could play a key role in repairing damaged retinas and acupuncture treatment leaves a patient seeing lights.

This week, Glaukos reports positive results from 2 glaucoma trials, CorNeat Vision’s artificial cornea is implanted into its first trial participant and Notal Vision tests out their at-home OCT platform for monitoring AMD.

This retrospective, interventional case series evaluated the long-term safety and efficacy of accelerated transepithelial CXL in pediatric eyes with progressive keratoconus.

This single-center retrospective study analyzes consultations managed by an ophthalmic hospitalist covering a children's hospital.